Latest filing published 30 Jun 2026 for Hansoh Pharmaceutical Group Co. Ltd., €33k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Lyu Aifeng is a declared insider of Hansoh Pharmaceutical Group Co. Ltd. (chief executive), with filings sourced from HKEX. Between 15 June 2020 and 27 June 2026, the trades on record add up to 30 filings.
On the open market, the record shows 7 purchases and 8 sales worth €1.3M. No amount is published for 14 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 1 purchase and 3 sales.
The record was last updated on 30 June 2026 with a transaction (€33k) in Hansoh Pharmaceutical Group Co. Ltd. The most recent open-market purchase was published on 4 May 2026, 173 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 5 days. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations